Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases
Susceptibility and disease course of COVID-19 among patients with inflammatory bowel diseases (IBD) are unclear and epidemiological data on the topic are still limited. There is some concern that patients with immuno-mediated diseases such as IBD, which are frequently treated with immunosuppressive...
Saved in:
Main Authors: | Angelica Corrias (Author), Gian Mario Cortes (Author), Flaminia Bardanzellu (Author), Alice Melis (Author), Vassilios Fanos (Author), Maria Antonietta Marcialis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What you have to know about Human Milk Oligosaccharides
by: Vassilios Fanos, et al.
Published: (2018) -
Once we were bacteria... mitochondria to infinity and beyond
by: Flaminia Bardanzellu, et al.
Published: (2018) -
Epidemiology of SARS-CoV-2: numbers matter!
by: Giorgia Casti, et al.
Published: (2020) -
COVID-19 and School: To Open or Not to Open, That Is the Question. The First Review on Current Knowledge
by: Francesco Busa, et al.
Published: (2021) -
How could metabolomics change pediatric health?
by: Flaminia Bardanzellu, et al.
Published: (2020)